However, due to discrepancies in findings from clinical trials, real-world data, and fundamental research, definitive recommendations for diabetic retinopathy screening prior to GLP-1 RA treatment initiation remain elusive
I am also selective about who I put on this medication and often like to have another helpful reason to utilize LDN
This medicine has demonstrated good safety parameters in preclinical studies and early clinical trials
The ending, so you know, is amazing
While these Phase 3 trials focus primarily on obesity and diabetes (with liver outcomes as secondary endpoints), the combination of Phase 2a liver data and Phase 3 weight loss results suggests retatrutide could become the first FDA-approved medication specifically for MASLD/NASH treatment
Adequate hydration with fluids through an IV should be provided based on what caused the rhabdomyolysis